Presentation talks

- The 60 min recording of the webinar covers : 

 ♦ The use of biomarkers and surrogate endpoints in drug development. 
 ♦ The concepts of prognostic/predictive biomarkers and surrogate endpoints. 
 ♦ The Statistical techniques, criteria and study designs appropriate for the clinical validation of  these various types of biomarkers.

  - The speakers were Dr Marc Buyse, Chairman IDDI and Prof Tomasz Burzykowski, VP Research IDDI.


A webcast presented at the AACR Annual Meeting 2008, San Diego, 12-16 April. FREE unrestricted ACCESS.


A web-lecture from the Edinburgh Clinical Trials Group  talks by Prof. Peter Sandercock. FREE unrestricted ACCESS.
This 40 minutes talk covers the following topics:
♦ Specific barriers to independent studies
♦ Impact of Privacy laws on trial conduct
♦ Identifying and reporting adverse events
♦ Economics of trials
♦ Challenges of trials in vulnerable populations

Courtesy of Professor Peter Sandercock - Professor of Medical Neurology at the Western General Hospital in Edinburgh and the Edinburgh Clinical Trials Group.


35 minutes of interesting, challenging and thought provoking information on practices in the design and analyses of clinical trials as it relates to biomarkers and surrogate endpoints. FREE unrestricted ACCESS .


 A powerpoint presentation presented by Dr Dennis Slamon, at the 2009 SABCS, San Antonio, Texas.